See the DrugPatentWatch profile for cosentyx
Based on the information available, it is generally safe to receive a flu shot shortly after receiving Cosentyx (secukinumab) [1]. However, it is always best to consult with a healthcare provider before receiving any vaccinations or injections, as they can provide personalized advice based on an individual's medical history and current medications [2].
Cosentyx is a medication used to treat a variety of conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body [1].
Flu shots, on the other hand, are vaccines that help protect against the influenza virus [3]. They are typically made using inactivated or weakened viruses, or pieces of the virus [3].
According to DrugPatentWatch.com, there are currently no known interactions between Cosentyx and the flu shot [4]. However, it is still important to consult with a healthcare provider before receiving any vaccinations or injections, as they can provide personalized advice based on an individual's medical history and current medications [2].
In summary, it is generally safe to receive a flu shot shortly after receiving Cosentyx, but it is always best to consult with a healthcare provider before receiving any vaccinations or injections.
Sources:
1. Cosentyx (secukinumab) [Internet]. Drugs.com. [cited 2022 Nov 22]. Available from: <
https://www.drugs.com/cosentyx.html>.
2. Vaccines and Immunizations: What You Need to Know [Internet]. Mayo Clinic. 2021 [cited 2022 Nov 22]. Available from: <
https://www.mayoclinic.org/tests-procedures/vaccines/about/pac-20395149>.
3. Influenza (Flu) Vaccine [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2022 Nov 22]. Available from: <
https://www.cdc.gov/vaccines/vpd/flu/hcp/recommendations.html>.
4. Secukinumab and Influenza Vaccine Interactions [Internet]. DrugPatentWatch.com. [cited 2022 Nov 22]. Available from: <
https://www.drugpatentwatch.com/interactions/secukinumab-influenza-vaccine>.